The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening
Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation...
Gespeichert in:
Veröffentlicht in: | Fetal diagnosis and therapy 2002-01, Vol.17 (1), p.17-21 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 21 |
---|---|
container_issue | 1 |
container_start_page | 17 |
container_title | Fetal diagnosis and therapy |
container_volume | 17 |
creator | Tišlarić, Dubravka Brajenović-Milić, Bojana Ristić, Smiljana Latin, Višnja Žuvić-Butorac, Marta Bačić, Josip Petek, Marijan Kapović, Miljenko |
description | Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p < 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p < 0.001) and nonsmokers (p < 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on. |
doi_str_mv | 10.1159/000047999 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000047999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71410599</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-4a368d012aee010a3a0f5fe6ec9a2a9ce2184edeb4389688e11d4bf03cc9e45b3</originalsourceid><addsrcrecordid>eNpt0E9LHDEYBvBQlKqrh54LEgoVPIzNO8nMJMei9Q-stLDrechm3ui4M8ma7FD25tfo1-snaeouLoi5JIff--bhIeQTsDOAQn1j6YhKKfWB7IPIIVOqFDvpzaDIuOTVHjmI8TEpWfHyI9kDkIznwPbJdPqA9MbZbkBnkHpLJ72ft-6eatfQXzq0yxX1jk4wDD291WGOIVLrA73wv93f5z-RTlauCb5HOjEB0aXZQ7JrdRfxaHOPyN3lj-n5dTb-eXVz_n2cGS6LZSY0L2XDINeIDJjmmtnCYolG6VwrgzlIgQ3OBJeqlBIBGjGzjBujUBQzPiIn672L4J8GjMu6b6PBrtMO_RDrCgSwQqkEv7yBj34ILmWr8zznlaqYSOh0jUzwMQa09SK0vQ6rGlj9v-f6tedkjzcLh1mPzVZuik3g6wboaHRng3amjVvHRVUyBttkcx3uMbyCy4vpy0_1orEJfX4XrbP8A0NemQ4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222379704</pqid></control><display><type>article</type><title>The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening</title><source>Karger Journal Archive Collection</source><source>MEDLINE</source><source>Karger Journals</source><source>Alma/SFX Local Collection</source><creator>Tišlarić, Dubravka ; Brajenović-Milić, Bojana ; Ristić, Smiljana ; Latin, Višnja ; Žuvić-Butorac, Marta ; Bačić, Josip ; Petek, Marijan ; Kapović, Miljenko</creator><creatorcontrib>Tišlarić, Dubravka ; Brajenović-Milić, Bojana ; Ristić, Smiljana ; Latin, Višnja ; Žuvić-Butorac, Marta ; Bačić, Josip ; Petek, Marijan ; Kapović, Miljenko</creatorcontrib><description>Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p < 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p < 0.001) and nonsmokers (p < 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on.</description><identifier>ISSN: 1015-3837</identifier><identifier>EISSN: 1421-9964</identifier><identifier>DOI: 10.1159/000047999</identifier><identifier>PMID: 11803210</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Adolescent ; Adult ; alpha-Fetoproteins - analysis ; Biological and medical sciences ; Biomarkers - blood ; Chorionic Gonadotropin, beta Subunit, Human - blood ; Chromosome aberrations ; Down Syndrome - diagnosis ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Management. Prenatal diagnosis ; Mass Screening ; Medical genetics ; Medical sciences ; Middle Aged ; Parity ; Pregnancy - blood ; Pregnancy Trimester, Second ; Pregnancy. Fetus. Placenta ; Prenatal Diagnosis ; Smoking</subject><ispartof>Fetal diagnosis and therapy, 2002-01, Vol.17 (1), p.17-21</ispartof><rights>2002 S. Karger AG, Basel</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2002 S. Karger AG, Basel</rights><rights>Copyright (c) 2002 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-4a368d012aee010a3a0f5fe6ec9a2a9ce2184edeb4389688e11d4bf03cc9e45b3</citedby><cites>FETCH-LOGICAL-c385t-4a368d012aee010a3a0f5fe6ec9a2a9ce2184edeb4389688e11d4bf03cc9e45b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2422,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13476001$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11803210$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tišlarić, Dubravka</creatorcontrib><creatorcontrib>Brajenović-Milić, Bojana</creatorcontrib><creatorcontrib>Ristić, Smiljana</creatorcontrib><creatorcontrib>Latin, Višnja</creatorcontrib><creatorcontrib>Žuvić-Butorac, Marta</creatorcontrib><creatorcontrib>Bačić, Josip</creatorcontrib><creatorcontrib>Petek, Marijan</creatorcontrib><creatorcontrib>Kapović, Miljenko</creatorcontrib><title>The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening</title><title>Fetal diagnosis and therapy</title><addtitle>Fetal Diagn Ther</addtitle><description>Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p < 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p < 0.001) and nonsmokers (p < 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on.</description><subject>Adolescent</subject><subject>Adult</subject><subject>alpha-Fetoproteins - analysis</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Chorionic Gonadotropin, beta Subunit, Human - blood</subject><subject>Chromosome aberrations</subject><subject>Down Syndrome - diagnosis</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Management. Prenatal diagnosis</subject><subject>Mass Screening</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Parity</subject><subject>Pregnancy - blood</subject><subject>Pregnancy Trimester, Second</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Prenatal Diagnosis</subject><subject>Smoking</subject><issn>1015-3837</issn><issn>1421-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0E9LHDEYBvBQlKqrh54LEgoVPIzNO8nMJMei9Q-stLDrechm3ui4M8ma7FD25tfo1-snaeouLoi5JIff--bhIeQTsDOAQn1j6YhKKfWB7IPIIVOqFDvpzaDIuOTVHjmI8TEpWfHyI9kDkIznwPbJdPqA9MbZbkBnkHpLJ72ft-6eatfQXzq0yxX1jk4wDD291WGOIVLrA73wv93f5z-RTlauCb5HOjEB0aXZQ7JrdRfxaHOPyN3lj-n5dTb-eXVz_n2cGS6LZSY0L2XDINeIDJjmmtnCYolG6VwrgzlIgQ3OBJeqlBIBGjGzjBujUBQzPiIn672L4J8GjMu6b6PBrtMO_RDrCgSwQqkEv7yBj34ILmWr8zznlaqYSOh0jUzwMQa09SK0vQ6rGlj9v-f6tedkjzcLh1mPzVZuik3g6wboaHRng3amjVvHRVUyBttkcx3uMbyCy4vpy0_1orEJfX4XrbP8A0NemQ4</recordid><startdate>200201</startdate><enddate>200201</enddate><creator>Tišlarić, Dubravka</creator><creator>Brajenović-Milić, Bojana</creator><creator>Ristić, Smiljana</creator><creator>Latin, Višnja</creator><creator>Žuvić-Butorac, Marta</creator><creator>Bačić, Josip</creator><creator>Petek, Marijan</creator><creator>Kapović, Miljenko</creator><general>Karger</general><general>S. Karger AG</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200201</creationdate><title>The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening</title><author>Tišlarić, Dubravka ; Brajenović-Milić, Bojana ; Ristić, Smiljana ; Latin, Višnja ; Žuvić-Butorac, Marta ; Bačić, Josip ; Petek, Marijan ; Kapović, Miljenko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-4a368d012aee010a3a0f5fe6ec9a2a9ce2184edeb4389688e11d4bf03cc9e45b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>alpha-Fetoproteins - analysis</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Chorionic Gonadotropin, beta Subunit, Human - blood</topic><topic>Chromosome aberrations</topic><topic>Down Syndrome - diagnosis</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Management. Prenatal diagnosis</topic><topic>Mass Screening</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Parity</topic><topic>Pregnancy - blood</topic><topic>Pregnancy Trimester, Second</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Prenatal Diagnosis</topic><topic>Smoking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tišlarić, Dubravka</creatorcontrib><creatorcontrib>Brajenović-Milić, Bojana</creatorcontrib><creatorcontrib>Ristić, Smiljana</creatorcontrib><creatorcontrib>Latin, Višnja</creatorcontrib><creatorcontrib>Žuvić-Butorac, Marta</creatorcontrib><creatorcontrib>Bačić, Josip</creatorcontrib><creatorcontrib>Petek, Marijan</creatorcontrib><creatorcontrib>Kapović, Miljenko</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Fetal diagnosis and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tišlarić, Dubravka</au><au>Brajenović-Milić, Bojana</au><au>Ristić, Smiljana</au><au>Latin, Višnja</au><au>Žuvić-Butorac, Marta</au><au>Bačić, Josip</au><au>Petek, Marijan</au><au>Kapović, Miljenko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening</atitle><jtitle>Fetal diagnosis and therapy</jtitle><addtitle>Fetal Diagn Ther</addtitle><date>2002-01</date><risdate>2002</risdate><volume>17</volume><issue>1</issue><spage>17</spage><epage>21</epage><pages>17-21</pages><issn>1015-3837</issn><eissn>1421-9964</eissn><abstract>Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p < 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p < 0.001) and nonsmokers (p < 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>11803210</pmid><doi>10.1159/000047999</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1015-3837 |
ispartof | Fetal diagnosis and therapy, 2002-01, Vol.17 (1), p.17-21 |
issn | 1015-3837 1421-9964 |
language | eng |
recordid | cdi_crossref_primary_10_1159_000047999 |
source | Karger Journal Archive Collection; MEDLINE; Karger Journals; Alma/SFX Local Collection |
subjects | Adolescent Adult alpha-Fetoproteins - analysis Biological and medical sciences Biomarkers - blood Chorionic Gonadotropin, beta Subunit, Human - blood Chromosome aberrations Down Syndrome - diagnosis Female Gynecology. Andrology. Obstetrics Humans Management. Prenatal diagnosis Mass Screening Medical genetics Medical sciences Middle Aged Parity Pregnancy - blood Pregnancy Trimester, Second Pregnancy. Fetus. Placenta Prenatal Diagnosis Smoking |
title | The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A00%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Influence%20of%20Smoking%20and%20Parity%20on%20Serum%20Markers%20for%20Down%E2%80%99s%20Syndrome%20Screening&rft.jtitle=Fetal%20diagnosis%20and%20therapy&rft.au=Ti%C5%A1lari%C4%87,%20Dubravka&rft.date=2002-01&rft.volume=17&rft.issue=1&rft.spage=17&rft.epage=21&rft.pages=17-21&rft.issn=1015-3837&rft.eissn=1421-9964&rft_id=info:doi/10.1159/000047999&rft_dat=%3Cproquest_cross%3E71410599%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222379704&rft_id=info:pmid/11803210&rfr_iscdi=true |